Đang chuẩn bị liên kết để tải về tài liệu:
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O6 -methylguanine DNA methyltransferase (MGMT) methylation and protein expression have been related to colorectal cancer treatment failure and tumor progression. |

TÀI LIỆU LIÊN QUAN

Stage and tissue-specific prognostic impact of miR-182 in NSCLC

Psychosocial impact of prognostic genetic testing in uveal melanoma patients: A controlled prospective clinical observational study

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium

Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

Primary Tumor Vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: Their relationships with clinicopathological characteristics and prognostic impact

The prognostic impact of macroscopic serosal change on resectable advanced gastric cancer

Assessing the impact of MRI based diagnostics on pre-treatment disease classifcation and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population

The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010

Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer

Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis